The German national disease management guideline "chronic heart failure";Nationale VersorgungsLeitlinie Chronische Herzinsuffizienz

Deutsche Medizinische Wochenschrift

Volumn 137, Issue 5, 2012, Pages 219-226

  Weinbrenner, S ^a   Langer, T ^a   Scherer, M ^b   Stork S ^c   Ertl, G ^c   Muth, Ch ^d   Hoppe, U C ^e   Kopp, I ^f   Ollenschlger, G ^a  

^a Arztliches Zentrum fur Qualitat in der Medizin   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^e Paracelsus Medizinische Privatniversität Salzburg Universitätsklinik für Innere Medizin II Salzburger Landeskliniken   (Austria)

^f PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

chronic heart failure; disease management guideline; elderly people; health care management; multi morbidity

Indexed keywords

HEART FAILURE; PRACTICE GUIDELINE; REVIEW;

AGE FACTORS; AGED; CHRONIC DISEASE; COMORBIDITY; COOPERATIVE BEHAVIOR; DISEASE MANAGEMENT; GERMANY; HEART FAILURE; HUMANS; INTERDISCIPLINARY COMMUNICATION; QUALITY IMPROVEMENT; RISK FACTORS;

EID: 84856272718     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0031-1292894     Document Type: Review

References (47)

1. Angermann C, Hoyer C, Ertl G. Abklrung von Luftnot. Clin Res Cardiol: 2006; 95 57 70
2. Angermann CE. Comorbidities in heart failure: a key issue. Eur J Heart Fail: 2009; 8 i5 i10
3. Arnold JM, Howlett JG, Dorian P et al. Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol: 2007; 23 21 45 (Pubitemid 46403407)
4. Arnold JM, Liu P, Demers C et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol: 2006; 22 23 45
5. rztliches Zentrum fr Qualitt in der Medizin (ZQ), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) Deutsches Instrument zur methodischen Leitlinien-Bewertung (DELBI). Z Arztl Fortbild Qualitatssich: 2005; 99 468 519
6. Braunstein JB, Anderson GF et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol: 2003; 42 1226 1233 (Pubitemid 37188347)
7. CIBIS II Investigators and Committees The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II). Lancet: 1999; 353 9 13
8. Cleland JG, Cohen-Solal A, Aguilar JC et al. Management of heart failure in primary care. Lancet: 2002; 360 1631 1639
9. CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med: 1987; 316 1429 1435
10. Dickstein K, Cohen-Solal A, Filippatos G et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J: 2008; 29 2388 2442
11. Flather MD, Shibata MC et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J: 2005; 26 215 225 (Pubitemid 40222359)
12. Flesch M, Komajda M, Lapuerta P et al. Leitliniengerechte Herzinsuffizienzbehandlung in Deutschland. Ergebnisse der MAHLER-Studie. Dtsch Med Wochenschr: 2005; 130 2191 2197 (Pubitemid 41433146)
13. Gislason GH, Rasmussen JN, Abildstrom SZ et al. Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes. Circulation: 2007; 116 737 744 (Pubitemid 47255991)
14. Heart Failure Society Of America HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail: 2006; 12 e1 e2
15. Herrmann-Lingen C. Herzinsuffizienz und Herztransplantation. In: Herrmann-Lingen C, Albus C, Titscher G. Psychokardiologie Ein Praxisleitfaden fr rzte und Psychologen. Kln Deutscher rzte-Verlag: 2008; 160 176
16. Hobbs FD, Kenkre JE et al. Impact of heart failure and left ventricular systolic dysfunction on quality of life. Eur Heart J: 2002; 23 1867 1876
17. Hoppe UC, Bohm M, Dietz R et al. Leitlinien zur Therapie der chronischen Herzinsuffizienz. Z Kardiol: 2005; 94 488 509 (Pubitemid 41124489)
18. Hunt SA, Abraham WT, Chin MH et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. Circulation: 2005; 112 12 e154 e235
19. Jong P, Vowinckel E, Liu PP et al. Prognosis and determinants of survival in patients newly hospitalized for heart failure. Arch Intern Med: 2002; 162 1689 1694
20. Jnger J, Schellberg D, Mller-Tasch T et al. Depression increasingly predicts mortality in the course of congestive heart failure. Eur J Heart Fail: 2005; 7 261 267 (Pubitemid 40215622)
21. Komajda M, Lapuerta P, Hermans N et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J: 2005; 26 1653 1659 (Pubitemid 41389697)
22. Korb K, Hummers-Pradier E et al. Umsetzung von diagnostischen Empfehlungen bei Herzinsuffizienz. Dtsch Med Wochenschr: 2010; 135 120 124
23. Krum H, Roecker EB, Mohacsi P et al. Effects of initiating carvedilol in patients with severe chronic heart failure. JAMA: 2003; 289 712 718 (Pubitemid 37430365)
24. LaRosa JC. Poor compliance: the hidden risk factor. Curr Atheroscler Rep: 2000; 2 1 4
25. Lip GY, Gibbs CR, Beevers DG. ABC of heart failure. BMJ: 2000; 320 104 107
26. Luthi JC, McClellan WM, Flanders WD et al. Variations in quality of care for heart failure. Swiss Med Wkly: 2006; 136 268 273 (Pubitemid 43773917)
27. Malcom J, Arnold O, Howlett JG et al. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure 2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. Can J Cardiol: 2008; 24 21 40 (Pubitemid 351385400)
28. MERIT-HF Study Group Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet: 1999; 353 2001 2007
29. Michalsen A, Knig G, Thimme W. Preventable causative factors leading to hospital admission with decompensated heart failure. Heart: 1998; 80 437 441 (Pubitemid 28535528)
30. Miche E, Herrmann G, Wirtz U et al. Effects of education, self-care instruction and physical exercise on patients with chronic heart failure. Z Kardiol: 2003; 92 985 993 (Pubitemid 38117515)
31. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart: 2007; 93 1137 1146 (Pubitemid 47311002)
32. Murray SA, Boyd K, Kendall M et al. Dying of lung cancer or cardiac failure: prospective qualitative interview study of patients and their carers in the community. BMJ: 2002; 325 929
33. Muth C, Gensichen J, Butzlaff M. DEGAM Leitlinie Nr. 9, Herzinsuffizienz. Dsseldorf Omikron Publishers: 2006
34. National Collaborating Centre for Chronic Conditions (NCC-CC), National Institute for Clinical Excellence (NICE) Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care. Clinical guideline No. 5. 2003 [cited: 2008 Nov 10]. http://www.nice.org.uk
35. Neumann T, Biermann J, Erbel R et al. Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int: 2009; 106 269 275
36. Peters-Klimm F, Muller-Tasch T et al. Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy. Clin Res Cardiol: 2008; 97 244 252 (Pubitemid 351464525)
37. Pitt B, Remme W, Zannad F et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med: 2003; 348 1309 1321 (Pubitemid 36384098)
38. Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med: 1999; 341 709 717 (Pubitemid 29407370)
39. Rutledge T, Reis VA, Linke SE et al. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol: 2006; 48 1527 1537 (Pubitemid 44528168)
40. Scherer M, Stanske B, Wetzel D et al. Psychische Kosymptomatik von hausrztlichen Patienten mit Herzinsuffizienz. Herz: 2006; 31 347 354 (Pubitemid 44046498)
41. Scottish Intercollegiate Guidelines Network (SIGN) Management of chronic heart failure. Edinburgh SIGN: 2007; (SIGN Publications; 95). Available from: http://www.sign.ac.uk
42. Statistisches Bundesamt Krankenhauspatienten. 2009; [cited: 2011 Feb 15]. http://www.destatis.de
43. Statistisches Bundesamt Todesursachen. 2009; [cited: 2011 Feb 15]. http://www.destatis.de
44. Stewart S, MacIntyre K, Capewell S et al. Heart failure and the aging population: an increasing burden in the 21st century? Heart: 2003; 89 49 53 (Pubitemid 36044289)
45. Strk S, Hense HW, Zentgraf C et al. Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure. Eur J Heart Fail: 2008; 10 1236 1245
46. The SOLVD Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med: 1992; 327 685 691
47. Zentgraf C. Zum Stand der Versorgungssituation der chronischen Herzinsuffizienz. Eine prospektive Analyse an 1054 konsekutiv rekrutierten Patienten am Interdisziplinren Herzinsuffizienzregister Wrzburg. Dissertation Julius-Maximilians-Universitt Wrzburg: 2007